BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 25463545)

  • 1. Effect of albumin in cirrhotic patients with infection other than spontaneous bacterial peritonitis. A randomized trial.
    Thévenot T; Bureau C; Oberti F; Anty R; Louvet A; Plessier A; Rudler M; Heurgué-Berlot A; Rosa I; Talbodec N; Dao T; Ozenne V; Carbonell N; Causse X; Goria O; Minello A; De Ledinghen V; Amathieu R; Barraud H; Nguyen-Khac E; Becker C; Paupard T; Botta-Fridlung D; Abdelli N; Guillemot F; Monnet E; Di Martino V
    J Hepatol; 2015 Apr; 62(4):822-30. PubMed ID: 25463545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Albumin for bacterial infections other than spontaneous bacterial peritonitis in cirrhosis. A randomized, controlled study.
    Guevara M; Terra C; Nazar A; Solà E; Fernández J; Pavesi M; Arroyo V; Ginès P
    J Hepatol; 2012 Oct; 57(4):759-65. PubMed ID: 22732511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of 4% gelofusine plus antibiotics on renal impairment and mortality in high-risk cirrhotic patients with spontaneous bacterial peritonitis.
    Sirinthornpunya S; Luangvichcharoen K
    J Med Assoc Thai; 2013 Mar; 96 Suppl 3():S77-83. PubMed ID: 23682527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal failure in patients with cirrhosis and sepsis unrelated to spontaneous bacterial peritonitis: value of MELD score.
    Terra C; Guevara M; Torre A; Gilabert R; Fernández J; Martín-Llahí M; Baccaro ME; Navasa M; Bru C; Arroyo V; Rodés J; Ginès P
    Gastroenterology; 2005 Dec; 129(6):1944-53. PubMed ID: 16344063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of intravenous albumin on endotoxin removal, cytokines, and nitric oxide production in patients with cirrhosis and spontaneous bacterial peritonitis.
    Chen TA; Tsao YC; Chen A; Lo GH; Lin CK; Yu HC; Cheng LC; Hsu PI; Tsai WL
    Scand J Gastroenterol; 2009; 44(5):619-25. PubMed ID: 19191184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis.
    Sort P; Navasa M; Arroyo V; Aldeguer X; Planas R; Ruiz-del-Arbol L; Castells L; Vargas V; Soriano G; Guevara M; Ginès P; Rodés J
    N Engl J Med; 1999 Aug; 341(6):403-9. PubMed ID: 10432325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Albumin infusion improves outcomes of patients with spontaneous bacterial peritonitis: a meta-analysis of randomized trials.
    Salerno F; Navickis RJ; Wilkes MM
    Clin Gastroenterol Hepatol; 2013 Feb; 11(2):123-30.e1. PubMed ID: 23178229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spontaneous bacterial peritonitis is a risk factor for renal failure requiring dialysis in waitlisted liver transplant candidates.
    Karagozian R; Rutherford AE; Christopher KB; Brown RS
    Clin Transplant; 2016 May; 30(5):502-7. PubMed ID: 26854749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of low dose albumin administration in spontaneous bacterial peritonitis on renal function and survival.
    Elloumi H; Sabbah M; Bibani N; Trad D; Elleuch N; Gargouri D; Ouakaa A; Kharrat J
    Arab J Gastroenterol; 2019 Dec; 20(4):205-208. PubMed ID: 31759874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Albumin infusion in cirrhotic patients with infections other than spontaneous bacterial peritonitis: End of the story?
    Merli M; Lucidi C; Lattanzi B; Riggio O
    J Hepatol; 2015 Sep; 63(3):767-8. PubMed ID: 25988298
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term clinical outcome of large volume paracentesis with intravenous albumin in patients with spontaneous bacterial peritonitis: a randomized prospective study.
    Choi CH; Ahn SH; Kim DY; Lee SK; Park JY; Chon CY; Moon YM; Han KH
    J Gastroenterol Hepatol; 2005 Aug; 20(8):1215-22. PubMed ID: 16048569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study.
    Martín-Llahí M; Pépin MN; Guevara M; Díaz F; Torre A; Monescillo A; Soriano G; Terra C; Fábrega E; Arroyo V; Rodés J; Ginès P;
    Gastroenterology; 2008 May; 134(5):1352-9. PubMed ID: 18471512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of intravenous albumin on systemic and hepatic hemodynamics and vasoactive neurohormonal systems in patients with cirrhosis and spontaneous bacterial peritonitis.
    Fernández J; Navasa M; Garcia-Pagan JC; G-Abraldes J; Jiménez W; Bosch J; Arroyo V
    J Hepatol; 2004 Sep; 41(3):384-90. PubMed ID: 15336440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of albumin treatment in patients with spontaneous bacterial peritonitis.
    Poca M; Concepción M; Casas M; Alvarez-Urturi C; Gordillo J; Hernández-Gea V; Román E; Guarner-Argente C; Gich I; Soriano G; Guarner C
    Clin Gastroenterol Hepatol; 2012 Mar; 10(3):309-15. PubMed ID: 22094025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reply to "Albumin infusion in cirrhotic patients with non-SBP infections: End of the story?".
    Thevenot T; Monnet E; di Martino V;
    J Hepatol; 2015 Sep; 63(3):768-9. PubMed ID: 25998162
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of ascites in patients with liver cirrhosis without neither hyponatremia nor renal insufficiency. Results of a randomized study comparing diuretics and punctures compensated by albumin].
    Hagège H; Ink O; Ducreux M; Pelletier G; Buffet C; Etienne JP
    Gastroenterol Clin Biol; 1992; 16(10):751-5. PubMed ID: 1478401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and Safety of IV albumin for non-spontaneous bacterial peritonitis infection among patients with cirrhosis: A systematic review and meta-analysis.
    Wong YJ; Qiu TY; Tam YC; Mohan BP; Gallegos-Orozco JF; Adler DG
    Dig Liver Dis; 2020 Oct; 52(10):1137-1142. PubMed ID: 32586766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of different therapeutic modalities on systemic, renal, and hepatic hemodynamics and short-term outcomes in cirrhotic patients with spontaneous bacterial peritonitis.
    Salman TA; Edrees AM; El-Said HH; El-Abd OL; El-Azab GI
    Eur J Gastroenterol Hepatol; 2016 Jul; 28(7):777-85. PubMed ID: 27097354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of paracentesis-induced circulatory dysfunction in cirrhosis: standard vs half albumin doses. A prospective, randomized, unblinded pilot study.
    Alessandria C; Elia C; Mezzabotta L; Risso A; Andrealli A; Spandre M; Morgando A; Marzano A; Rizzetto M
    Dig Liver Dis; 2011 Nov; 43(11):881-6. PubMed ID: 21741331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human albumin infusion is safe and effective even in patients without acute kidney injury and spontaneous bacterial peritonitis.
    Kulkarni AV; Zuberi AA; Chaitanya K; Doolam H; Reddy S; Lakshmi PK; Godbole S; Shantan V; Iyengar S; Alla M; Sharma M; Reddy DN; Rao PN
    Indian J Gastroenterol; 2024 Apr; 43(2):485-493. PubMed ID: 38085502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.